Testing effectiveness (Phase 2)Study completedNCT01112384
What this trial is testing
SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas
Who this might be right for
Metastatic Sarcoma
NCIC Clinical Trials Group 24
Showing 20 of 0 results